Skip Nav Destination
LETTER|
July 15, 1994
Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter]
Blood (1994) 84 (2): 666–667.
Citation
P Fenaux, E Wattel, E Archimbaud, M Sanz, B Hecquet, N Fegueux, A Guerci, H Link, M Fey, S Castaigne; Prolonged follow-up confirms that all-trans retinoic acid followed by chemotherapy reduces the risk of relapse in newly diagnosed acute promyelocytic leukemia. The French APL Group [letter]. Blood 1994; 84 (2): 666–667. doi: https://doi.org/10.1182/blood.V84.2.666.666
Download citation file:
July 15 1994
Advertisement intended for health care professionals
31
Crossref
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal